Home > Insider Trading > Filing (0001209191-13-018094)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
802724	Insite Vision Inc	INSV	Pharmaceutical Preparations (2834)	943015807

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1409751	Coliseum Capital Management, Llc	Metro Center 1 Station Place, 7Th Floor South Stamford CT 06902		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-03-20	82,200	$0.34	14,321,138	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote

Footnotes

These securities are held directly by (a) Coliseum Capital Partners, L.P., an investment limited partnership of which Coliseum Capital, LLC, a Delaware limited liability company ("CC"), is general partner and for which Coliseum Capital Management, LLC, a Delaware limited liability company ("CCM"), serves as investment adviser, and (b) Blackwell Partners, LLC ("Blackwell"), a separate account investment advisory client of CCM. Christopher Shackelton and Adam Gray manage CCM and CC. Each of Christopher Shackelton, Adam Gray, Blackwell, CCP, CC and CCM disclaims beneficial ownership of these securities except to the extent of that person's pecuniary interest therein.
This transaction was executed in multiple trades at prices ranging from $0.34 to $0.35. The reported price reflects the weighted average purchase price. The Reporting Person filing this report hereby undertakes to provide upon request by the SEC staff, Insite Vision Inc. or a shareholder of Insite Vision Inc. full information regarding the number of shares purchased at each separate price.